Current therapy of myeloma induced renal failure.
Gertz
Morie A
MA
Hematology, Mayo clinic, Rochester, USA.
D001897:Boronic Acids / Q000009:adverse effects / Q000627:therapeutic use; D000069286:Bortezomib; D006801:Humans; D000077269:Lenalidomide; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy; D011719:Pyrazines / Q000009:adverse effects / Q000627:therapeutic use; D051437:Renal Insufficiency / Q000188:drug therapy* / Q000209:etiology; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use
D001897:Boronic Acids; D011719:Pyrazines; D013792:Thalidomide; D000069286:Bortezomib; D000077269:Lenalidomide